RNA epigenetics in pulmonary diseases: Insights into methylation modification of lncRNAs in lung cancer
Authors:
Open Access
- 14 May 2024
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 175, 116704
Abstract
No abstract availableKeywords
This publication has 133 references indexed in Scilit:
- Single-base resolution mapping of 2′-O-methylation sites by an exoribonuclease-enriched chemical methodScience China Life Sciences, 2022
- The regulatory role of long non- coding RNAs as a novel controller of immune response against cancer cellsMolecular Biology Reports, 2022
- A novel algorithm for lung adenocarcinoma based on N6 methyladenosine‐related immune long noncoding RNAs as a reliable biomarker for predicting survival outcomes and selecting sensitive anti‐tumor therapiesJournal of Clinical Laboratory Analysis, 2022
- The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibitionAnnals of Oncology, 2021
- N‐6 methylation‐related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironmentJournal of Clinical Laboratory Analysis, 2021
- N1‐methyladenosine profiling of long non‐coding RNA in colorectal cancerIUBMB Life, 2021
- Programmable RNA N1‐Methyladenosine Demethylation by a Cas13d‐Directed DemethylaseAngewandte Chemie International Edition, 2021
- Cancer statistics for the year 2020: An overviewInternational Journal of Cancer, 2021
- Long non‐coding RNA AGER‐1 functionally upregulates the innate immunity gene AGER and approximates its anti‐tumor effect in lung cancerMolecular Carcinogenesis, 2017
- Mechanisms of long noncoding RNA function in development and diseaseCellular and Molecular Life Sciences, 2016